共 50 条
Diallyl-disulfide, an organosulfur compound of garlic, attenuates airway inflammation via activation of the Nrf-2/HO-1 pathway and NF-kappaB suppression
被引:88
|作者:
Shin, In-Sik
[1
,2
]
Hong, Jumi
[1
,3
]
Jeon, Chan-Mi
[1
]
Shin, Na-Rae
[1
]
Kwon, Ok-Kyoung
[1
]
Kim, Hui-Seong
[1
,4
]
Kim, Jong-Choon
[2
]
Oh, Sei-Ryang
[1
]
Ahn, Kyung-Seop
[1
]
机构:
[1] Korea Res Inst Biosci & Biotechnol, Nat Med Res Ctr, Cheongwon Gun 363883, Chungbuk, South Korea
[2] Chonnam Natl Univ, Coll Vet Med, Kwangju 500757, South Korea
[3] Chungbuk Natl Univ, Cheongju 361763, Chungbuk, South Korea
[4] Univ Sci & Technol, Taejon 305806, South Korea
关键词:
Diallyl disulfide;
Antioxidant;
Antiinflammation;
Asthma;
HEME OXYGENASE-1;
LIPOPOLYSACCHARIDE;
CANCER;
EXPRESSION;
APOPTOSIS;
STRESS;
ASTHMA;
CELLS;
MODEL;
NRF2;
D O I:
10.1016/j.fct.2013.09.012
中图分类号:
TS2 [食品工业];
学科分类号:
0832 ;
摘要:
Diallyl disulfide (DADS) is a major organosulfur compound found in garlic oil that is widely used as a flavoring agent. In this study, we evaluated the effects of DADS on airway inflammation using an ovalbumin-induced model of allergic asthma and RAW264.7 cells. DADS decreased nitric oxide production with a reduction in the levels of interleukins (1)-1 beta and IL-6 in RAW264.7 cells stimulated with LPS. DADS also reduced the expression of proinflammatory proteins including inducible nitric oxide synthase (iNOS), nuclear factor (NF)-kappa B, and matrix metalloproteinase (MMP)-9, and it enhanced the expression of antioxidant proteins including Nrf-2 and hemeoxygenase (HO)-1. In in vivo experiments, DADS decreased the inflammatory cell count in the bronchoalveolar lavage fluid (BALF) with IL-4, IL-5, IL-13, and immunoglobulin (Ig) E. These results were consistent with the histological analysis. DADS attenuated the airway inflammation and mucus hypersecretion induced by OVA challenge. In addition, DADS induced the activation of Nrf-2 and the expression of HO-1. In contrast, DADS reduced the activation of NF-kappa B, iNOS and MMP-9. In conclusion, DADS reduced the airway inflammation via regulation of Nrf-2/HO-1 and NF-kappa B. These results suggest that DADS might represent a useful new oral therapy to treat allergic asthma. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:506 / 513
页数:8
相关论文